MC
KERX

Moors & Cabot’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Moors & Cabot’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,000
Closed -$72K – 553
2017
Q2 		$72K Hold
10,000
– – 0.01% 495
2017
Q1 		$61K Buy
+10,000
New +$61K 0.01% 496